Acurx Pharmaceuticals, Inc. Share Price
ACXPAcurx Pharmaceuticals, Inc. Stock Performance
Open $5.31 | Prev. Close $5.02 | Circuit Range N/A |
Day Range $5.02 - $5.31 | Year Range $3.95 - $37.10 | Volume 480 |
Average Traded $5.16 |
Acurx Pharmaceuticals, Inc. Share Price Chart
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Acurx Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $5.31 | $5.05 | +0.00% |
12-Nov-25 | $5.31 | $5.05 | -11.16% |
11-Nov-25 | $5.43 | $5.69 | +14.95% |
10-Nov-25 | $4.89 | $4.95 | +9.03% |
07-Nov-25 | $4.71 | $4.54 | -9.02% |
06-Nov-25 | $5.34 | $4.99 | -4.41% |
05-Nov-25 | $5.14 | $5.22 | +5.24% |